2,3,4,5-Tetramethoxyamphetamine
From Wikipedia, the free encyclopedia
|
2,3,4,5-Tetramethoxyamphetamine
|
|
| Systematic (IUPAC) name | |
| 1-(2,3,4,5-tetramethoxyphenyl)propan-2-amine | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C13H19NO4 |
| Mol. mass | ? |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Tetramethoxyamphetamine, or 2,3,4,5-tetramethoxyamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. Tetramethoxyamphetamine was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 50mg, and the duration unknown. Tetramethoxyamphetamine produces a threshold, mydriasis, and a headache. Very little data exists about its pharmacological properties, metabolism, and toxicity.

